DAX ®12.629,79+1,15%TecDAX ®2.805,82+0,07%Dow Jones27.024,80+0,89%NASDAQ 1007.942,85+1,28%

DGAP-CMS: Siemens Healthineers AG: Release of a capital market information

| Quelle: Dow Jones Newsw... | Lesedauer etwa 4 min. | Text vorlesen Stop Pause Fortsetzen

DGAP Post-admission Duties announcement: Siemens Healthineers AG /
Disclosure pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No.
596/2014 (MAR) and Art. 2 para. 1 of Delegated Regulation (EU) No. 2016/1052
Siemens Healthineers AG: Release of a capital market information

2019-09-20 / 15:33
Dissemination of a Post-admission Duties announcement transmitted by DGAP -
a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

*Disclosure pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No.
596/2014 (MAR) *
*and Art. 2 para. 1 of Delegated Regulation (EU) No. 2016/1052*

The share buyback resolved on 16 September 2019 by the Managing Board of
Siemens Healthineers AG (hereinafter also referred to as '*Company*') will
commence on 24 September 2019. In the time period until 31 January 2020,
treasury shares of the Company with a maximum value of EUR 70,000,000.00
(excluding incidental transaction charges) shall be acquired, in total,
however, no more than 2,100,000 no-par-value shares. The acquired shares
will be used in connection with share-based remuneration programs and,
respectively, employee stock programs of the Company or entities under its
control and will be delivered to persons who have or had an employment
relationship with the Company or an entity under its control, as well as to
board members of entities under the Company's control. To the extent that
the acquired shares are not required for such purpose, they may be used for
other legally permissible purposes. The Managing Board thereby exercises the
authorization granted by the Shareholders' Meeting of Siemens Healthineers
AG on 19 February 2018 to acquire treasury shares pursuant to Section 71
para. 1 no. 8 of the German Stock Corporation Act (_Aktiengesetz, AktG_).

A credit institution is mandated to carry out the buyback, making its
decisions on the date of the acquisition of shares independently and without
the influence of the Company. The right of the Company to terminate the
mandate of the credit institution and to confer the mandate to another
investment firm or credit institution in compliance with legal provisions
remains unaffected. The share buyback may be terminated, suspended and
resumed at any time, subject to compliance with legal provisions.

The buyback shall be implemented exclusively on the electronic trading
platform of the Frankfurt Stock Exchange (Xetra).

The purchase price per repurchased share (excluding incidental transaction
charges) must neither exceed the share price of a Siemens Healthineers
Share, as determined by the opening auction of a Siemens Healthineers Share
in XETRA trading (or a comparable successor system) by more than 10% nor
fall below such market price by more than 20%.

The credit institution is further obligated to comply with the trading
conditions of Art. 3 Delegated Regulation (EU) No. 2016/1052 (hereinafter
also referred to as '*Buyback Regulation*'). According to the Buyback
Regulation, _inter alia_, no purchase price may be paid which exceeds the
price of the last independent trade or the highest independent bid placed at
the time of the purchase on the stock exchange on which the purchase is
carried out, the higher of the two values being relevant. Furthermore,
pursuant to the Buyback Regulation, no more than 25% of the average daily
volume of shares on the stock exchange on which the purchase is carried out
may be acquired. The average volume of shares is based on the average daily
trade volume of the 20 trading days preceding the specific date of purchase.

The transactions will be announced pursuant to the requirements of Art. 2
para. 3 Buyback Regulation in a detailed and an aggregated form no later
than on the seventh trading day after their execution. Furthermore, Siemens
Healthineers AG will publish the transactions on its website under
https://www.corporate.siemens-healthineers.com/investor-relations/share and
ensure that the information will be publicly accessible for a period of at
least five years from the day of disclosure.

Munich, 20 September 2019

Siemens Healthineers AG

The Managing Board

2019-09-20 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
Language: English
Company: Siemens Healthineers AG
Henkestr. 127
91052 Erlangen
Internet: https://www.corporate.siemens-healthineers.com

End of News DGAP News Service

877445 2019-09-20

(END) Dow Jones Newswires

September 20, 2019 09:33 ET ( 13:33 GMT)

Passende Hebelprodukte von

WKN Bezeichnung Hebel
Long  DS3HEE SIEMENS H WaveUnlimited L 31.6375 (DBK) 7,668
Short  DS3HEN SIEMENS H WaveUnlimited S 39.2627 (DBK) 6,656

Das könnte Sie auch interessieren



Aktuelle Videos

zur Mediathek

Diese Seite empfehlenschliessen
Interessant, oder?
Teilen Sie diese Seite auf Facebook oder Twitter
Wenn Sie auf die Teilen-Buttons klicken und sich bei den Betreibern einloggen, werden Daten an den jeweiligen Betreiber übermittelt. Bitte beachten Sie die Datenschutzerklärung.
Aktuelle Umfrageschliessen
Finden Sie es richtig und wichtig, dass die EU die zur Thomas Cook gehörenden Airline-Tochter Condor mit einem Staatskredit unterstützt?
Jetzt abstimmen!
Alle Umfragen ansehen